# CYB5R2

## Overview
CYB5R2 is a gene that encodes the enzyme cytochrome b5 reductase 2, a member of the flavoprotein pyridine nucleotide cytochrome reductase family. This enzyme is integral to electron transfer processes, playing a pivotal role in oxidation-reduction reactions, lipid metabolism, and the desaturation and elongation of fatty acids. It is active in cellular compartments such as the endoplasmic reticulum and mitochondria, where it facilitates the reduction of cytochrome b5, thereby influencing various metabolic pathways (Deng2011Structural; Xiao2013Cytochrome). The enzyme's activity is crucial for processes such as cholesterol biosynthesis, drug metabolism, and the maintenance of hemoglobin in erythrocytes (Ming2015Cytochrome). CYB5R2's involvement in these pathways underscores its importance in maintaining cellular homeostasis and its potential implications in various diseases, including cancer, where its expression and regulation can significantly impact disease progression and patient prognosis (Ma2022Molecular; Liu2015Genetic).

## Structure
CYB5R2 (cytochrome b5 reductase 2) is an enzyme involved in electron transfer processes. Its primary structure is composed of a sequence of amino acids forming a polypeptide chain. The secondary structure of CYB5R2 includes alpha helices and beta sheets, which contribute to its overall stability and function. The tertiary structure is characterized by the three-dimensional folding of the protein, often stabilized by disulfide bonds, which are crucial for maintaining its functional conformation.

CYB5R2 contains a FAD-binding domain, which is essential for its enzymatic activity. This domain facilitates the binding of flavin adenine dinucleotide (FAD), a cofactor necessary for the enzyme's electron transfer function. The presence of this domain is a defining feature of the protein's structure and function.

Post-translational modifications, such as phosphorylation, can regulate the activity of CYB5R2, potentially altering its interaction with other molecules and its overall function. Additionally, splice variant isoforms of CYB5R2 may exist, which can lead to variations in its structure and function, allowing the protein to adapt to different cellular conditions or requirements. These structural features and modifications highlight the complexity and adaptability of CYB5R2 in its biological roles.

## Function
CYB5R2, or cytochrome b5 reductase 2, is a crucial enzyme involved in various electron transfer processes within healthy human cells. It is part of the flavoprotein pyridine nucleotide cytochrome reductase family and plays a significant role in oxidation-reduction reactions, lipid metabolism, and fatty acid desaturation and elongation (Xiao2013Cytochrome). The enzyme is also involved in cholesterol biosynthesis and drug metabolism, contributing to the detoxification of polycyclic aromatic hydrocarbons and arylhydroxylamine carcinogens, which are commonly found in cigarette smoke and fried foods (Xiao2013Cytochrome).

CYB5R2 is active in the endoplasmic reticulum and mitochondria, where it facilitates the reduction of cytochrome b5, impacting various metabolic pathways (Deng2011Structural). In erythrocytes, CYB5R2 is responsible for methemoglobin reduction, which is essential for maintaining hemoglobin in its functional state (Ming2015Cytochrome). The enzyme also plays a role in the desaturation process of fatty acids by providing necessary electrons for the turnover of fatty acid desaturase, highlighting its importance in lipid metabolism (Ming2015Cytochrome). These functions underscore CYB5R2's role in maintaining cellular and organismal homeostasis.

## Clinical Significance
The CYB5R2 gene, also known as cytochrome b5 reductase 2, has been implicated in various diseases due to alterations in its expression and genetic mutations. In multifocal and multicentric glioblastoma (M-GBM), CYB5R2 is overexpressed and associated with poorer survival outcomes. This overexpression is linked to lower methylation levels of its promoter region, suggesting an epigenetic regulation mechanism. High CYB5R2 expression correlates with shorter survival durations in glioblastoma patients, independent of tumor grade (Liu2015Genetic).

In nasopharyngeal carcinoma (NPC), CYB5R2 acts as a tumor suppressor gene. Its expression is frequently downregulated due to promoter hypermethylation, which is associated with lymph node metastasis. Restoring CYB5R2 expression in NPC cells has been shown to inhibit tumor growth and cell migration, indicating its role in suppressing tumorigenicity (Xiao2013Cytochrome).

In CD5+ diffuse large B-cell lymphoma (DLBCL), high CYB5R2 expression is linked to poorer overall and progression-free survival, suggesting its role as an unfavorable prognostic factor (Ma2022Molecular). These findings highlight the clinical significance of CYB5R2 in various cancers, where its expression levels and epigenetic modifications can serve as potential biomarkers for prognosis and therapeutic targets.


## References


[1. (Ming2015Cytochrome) Huixin Ming, Ying Lan, Feng He, Xue Xiao, Xiaoying Zhou, Zhe Zhang, Ping Li, and Guangwu Huang. Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis. Chinese Journal of Cancer, August 2015. URL: http://dx.doi.org/10.1186/s40880-015-0044-4, doi:10.1186/s40880-015-0044-4. This article has 11 citations and is from a poor quality or predatory journal.](https://doi.org/10.1186/s40880-015-0044-4)

[2. (Deng2011Structural) Bin Deng, Sudharsan Parthasarathy, WenFang Wang, Ryan Sturms, Mark Hargrove, Brian Gibney, Kevin Battaile, Scott Lovell, David Benson, and Hao Zhu. Structural basis of ncb5or, a multi‐domain redox enzyme implicated in diabetes and lipid metabolism. The FASEB Journal, April 2011. URL: http://dx.doi.org/10.1096/fasebj.25.1_supplement.940.1, doi:10.1096/fasebj.25.1_supplement.940.1. This article has 0 citations.](https://doi.org/10.1096/fasebj.25.1_supplement.940.1)

[3. (Ma2022Molecular) Dongshen Ma, Yuhan Ma, Yuanyuan Ma, Jia Liu, Ying Gu, Nian Liu, Chenxi Xiang, Hui Liu, and Wei Sang. Molecular subtyping of cd5+ diffuse large b-cell lymphoma based on dna-targeted sequencing and lymph2cx. Frontiers in Oncology, August 2022. URL: http://dx.doi.org/10.3389/fonc.2022.941347, doi:10.3389/fonc.2022.941347. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.941347)

[4. (Xiao2013Cytochrome) Xue Xiao, Weilin Zhao, Fangyun Tian, Xiaoying Zhou, Jinyan Zhang, Tingting Huang, Bo Hou, Chunping Du, Shumin Wang, Yingxi Mo, Nana Yu, Shiping Zhou, Jinping You, Zhe Zhang, Guangwu Huang, and Xianjie Zeng. Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma. Tumor Biology, 35(4):3755–3763, December 2013. URL: http://dx.doi.org/10.1007/s13277-013-1497-1, doi:10.1007/s13277-013-1497-1. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13277-013-1497-1)

[5. (Liu2015Genetic) Qun Liu, Yuexin Liu, Wenliang Li, Xiaoguang Wang, Raymond Sawaya, Frederick F. Lang, W. K. Alfred Yung, Kexin Chen, Gregory N. Fuller, and Wei Zhang. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathologica, 130(4):587–597, September 2015. URL: http://dx.doi.org/10.1007/s00401-015-1470-8, doi:10.1007/s00401-015-1470-8. This article has 60 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00401-015-1470-8)